rs773527127
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The NM_032193.4(RNASEH2C):c.115G>T(p.Asp39Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000493 in 1,419,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D39N) has been classified as Uncertain significance.
Frequency
Consequence
NM_032193.4 missense
Scores
Clinical Significance
Conservation
Publications
- Aicardi-Goutieres syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- Aicardi-Goutieres syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASEH2C | NM_032193.4 | c.115G>T | p.Asp39Tyr | missense_variant | Exon 1 of 4 | ENST00000308418.10 | NP_115569.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000109 AC: 2AN: 182918 AF XY: 0.00000995 show subpopulations
GnomAD4 exome AF: 0.00000493 AC: 7AN: 1419906Hom.: 0 Cov.: 32 AF XY: 0.00000568 AC XY: 4AN XY: 703640 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: RNASEH2C c.115G>T (p.Asp39Tyr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.1e-05 in 182918 control chromosomes. c.115G>T has been reported in the literature in two compound heterozygous individuals affected with Aicardi Goutieres Syndrome (Ramantani_2010, Garau_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31130681, 20131292). ClinVar contains an entry for this variant (Variation ID: 464266). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Aicardi-Goutieres syndrome 3 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 39 of the RNASEH2C protein (p.Asp39Tyr). This variant is present in population databases (rs773527127, gnomAD 0.003%). This missense change has been observed in individuals with Aicardi–Goutières syndrome (PMID: 20131292, 31130681). ClinVar contains an entry for this variant (Variation ID: 464266). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at